Brain Research and Integrative Neuroscience Network for COVID-19
Brain Research and Integrative Neuroscience Network for COVID-19 (BRAINN)
University of Cyprus
70 participants
Nov 15, 2024
INTERVENTIONAL
Conditions
Summary
The aim of the experimental study is to investigate two interventions for the management of cognitive symptoms resulting from long COVID. Participants will be randomly assigned into two interventions. 1. Categorization Program (CP) training with active tDCS or 2. Categorization Program training with sham tDCS.
Eligibility
Inclusion Criteria2
- Reported cognitive difficulties due to COVID-19 infection
- WHO Long COVID criteria will be used
Exclusion Criteria1
- Significant history of neuropsychiatric conditions prior to contracting COVID-19; history of neurological conditions such as TBI, CVA, MS prior to contracting COVID-19.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participation in 15 one-hour sessions distributed over three weeks. During each session participants will receive two sessions of tDCS plus cognitive training with the Categorization Program
Participation in 15 one-hour sessions distributed over three weeks. During each session participants will receive cognitive training and sham tDCS
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06517706